Authors

• Adrian F. Hernandez (ORCID: https://orcid.org/0000-0003-3387-9616)
• Peter Farrehi (ORCID: https://orcid.org/0000-0003-1576-7557)
• Mark B. Effron (ORCID: https://orcid.org/0000-0003-4050-5030)
• Kamal Gupta (ORCID: https://orcid.org/0000-0002-2440-9033)
• WS Jones
• Lisa Wruck (ORCID: https://orcid.org/0000-0003-1732-9067)
• Hillary Mulder
• Daniel Muñoz (ORCID: https://orcid.org/0000-0003-3706-7092)
• Russell L. Rothman (ORCID: https://orcid.org/0000-0002-1506-3990)
• Saket R. Girotra (ORCID: https://orcid.org/0000-0002-4784-4513)
• Jeff Whittle (ORCID: https://orcid.org/0000-0002-9544-838X)
• Tamar S. Polonsky (ORCID: https://orcid.org/0000-0003-2112-9244)
• Guillaume Marquis‐Gravel (ORCID: https://orcid.org/0000-0003-2965-1504)
• Catherine P. Benziger (ORCID: https://orcid.org/0000-0002-8992-6197)
• Sunil Kripalani
• Robert A. Harrington

Institutions

• Essentia Health (US)
• Duke University (US)
• Medical College of Wisconsin (US)
• University of Michigan (US)
• Ochsner Medical Center (US)
• University of Chicago (US)
• Clinical Research Institute (US)
• Duke Medical Center (US)
• University of Kansas Medical Center (US)
• The University of Texas Southwestern Medical Center (US)
• Vanderbilt University Medical Center (US)
• Stanford University (US)

Publication Details

Journal

BMJ Open

Published

2024-08-01

DOI

https://doi.org/10.1136/bmjopen-2023-078197

Citations

2

Primary Topic

Antiplatelet Therapy and Cardiovascular Diseases

Type

article

Field-Weighted Citation Impact

0.80

Funders

• American Heart Association
• Bristol-Myers Squibb
• Eli Lilly and Company
• Bayer
• Patient-Centered Outcomes Research Institute
• Boston Scientific Corporation
• Moderna
• Université de Montréal
• Institut de Cardiologie de Montréal
• Canadian Institutes of Health Research
• National Heart, Lung, and Blood Institute
• Duke Clinical Research Institute
• Janssen Pharmaceuticals